0001213900-23-057497.txt : 20230718 0001213900-23-057497.hdr.sgml : 20230718 20230717181849 ACCESSION NUMBER: 0001213900-23-057497 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230718 DATE AS OF CHANGE: 20230717 EFFECTIVENESS DATE: 20230718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cadrenal Therapeutics, Inc. CENTRAL INDEX KEY: 0001937993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880860746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-487175 FILM NUMBER: 231092580 BUSINESS ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 BUSINESS PHONE: 904-300-0701 MAIL ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 D 1 primary_doc.xml X0708 D LIVE 0001937993 Cadrenal Therapeutics, Inc. 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 (904) 300-0701 DELAWARE None None Corporation true 2022 Quang Pham c/o Cadrenal Therapeutics, Inc. 822 A1A North, Suite 306 Ponte Vedra FL FLORIDA 32082 Executive Officer Director Chief Executive Officer Matthew Szot 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 Executive Officer CHIEF FINANCIAL OFFICER Douglas Losordo 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 Executive Officer CHIEF MEDICAL OFFICER John Murphy 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director STEVEN ZELENKOFSKE 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director Glynn Wilson 822 A1A NORTH, SUITE 306 PONTE VEDRA FL FLORIDA 32082 Director Biotechnology Decline to Disclose 06b false 2023-07-14 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 NY NEW YORK false 7500001 7500001 0 false 1 421875 0 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Cadrenal Therapeutics, Inc. /s/ Quang Pham Quang Pham Chief Executive Officer 2023-07-17